Pharmacological Management of Alcohol Withdrawal
JAMA 278:144-151, Mayo-Smith,M.F., 1997
The Diagnostic Evaluation & Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA 278:51-57, Gutmann,D.H.,et al, 1997
Stroke Patients'Knowledge of Stroke
Stroke 28:912-915, Williams,L.S.,et al, 1997
Outcomes of Stroke Patients in Medicare Fee for Service and Managed Care
JAMA 278:119-124, 1611997., Retchin,S.M.,et al, 1997
Knowledge of Risk Among Patients at Increased Risk for Stroke
Stroke 28:916-921, Samsa,G.P.,et al, 1997
Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke
Stroke 28:1480-1497, Culebras,A.,et al, 1997
Attitudes of US Neurologists Concerning the Ethical Dimensions of Managed Care
Neurol 49:4-13, Bernat,J.L.,et al, 1997
Managed Care and Neurologists:Ethical Considerations
Ethics & Humanities Subcomm of Practice Comm of AAN, Neurol 49:321-32297., , 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Silicone Breast Implants and Neurologic Disorders
Neurol 48:1504-1507, Ferguson,J.H., 1997
A Controlled Trial of an Educational Program to Prevent Low Back Injuries
NEJM 337:322-328, Daltrov,L.H.,et al, 1997
A Practical Approach to the Treatment of Vasospasm
AJNR 18:1653-1660, Eskridge,J.M.,et al, 1997
Generalized Efficacy of t-PA for Acute Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2119-21251997., , 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
Dermatomal Somatosensory Evoked Potentials
AAN Therapeutics & Technology Assessments Subcommittee, Neurol 49:1127-113097., , 1997
Optic Pathway Gliomas in Children with Neurofibromatosis 1:Consensus Stmt NF1 Optic Pathway Glioma Task Force
Ann Neurol 41:143-149, Listernick,R.,et al, 1997
Consensus Against Both Endarterectomy and Routine Screening for Asymptomatic Carotid Artery Stenosis
Arch Neurol 54:25-28, 231997., Perry,J.R.,et al, 1997
Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Withdrawing Intensive Life-Sustaining Treatment-Recommendations for Compassionate Clin Mgmt
NEJM 336:652-657, Brody,H.,et al, 1997
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Practice Parameters for the Diagnosis of Patients with Nervous System Lyme Borreliosis (Lyme Disease)
Neurol 46:619-627, 8811996., Halperin,J.J.,et al, 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Evaluation of Dementia
NEJM 335:330-336, 19961996., Geldmacher,D.S.&Whitehouse,P.J., 1996
Neuroimaging in the Emergency Patient Presenting with Seizure
Neurol 47:26-32, 2881996., Greenberg,M.K.,et al, 1996
Assessment:Electronystagmography, Report of the Therapeutics and Technology Assessment Subcommittee
Neurol 46:1763-1766, Ferguson,J.H.,et al, 1996
Practice Parameter:A Guideline for Discontinuing Antiepileptic Drugs in Seizure-Free Patients-Summary Statement
Neurol 47:600-602, Rosenberg,J.H., 1996
Practice Parameter:The Neurodiagnostic Evaluation of the Child with First Simple Febrile Seizure
Pediatrics 97:769-772, Bergman,D.A.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996
Factors Delaying Hospital Admission in Acute Stroke:The Copenhagen Stroke Study
Neurol 47:383-387, Jorgensen,H.S.,et al, 1996
US Nat'l Survey of Phy Pract for 2nd & Tertiary Prevent of Ischemic Stroke, Med Therapy in Carotid Art Stenosis
Stroke 27:1473-1478, Goldstein,L.B.,et al, 1996
Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996
US NEurologists:Attitudes on the US Health Care System
Neurol 47:279-287, Ringel,S.P.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Agreement on Disease-Specific Criteria for Do-Not-Resuscitate Orders in Acute Stroke
Stroke 27:232-237, Alexandrov,A.V.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Living with Parkinson's Disease
NEJM 334:114-116, Salzman,E.W., 1996
Factors Delaying Hospital Admission After Acute Stroke
Stroke 27:398-400, Fogelholm,R.,et al, 1996
Consensus Statement on the Definition of Orthostatic Hypotension, Pure Autonomic Failure, and Multiple System Atrophy
Neurol 46:1470, Schatz,I.J.,et al, 1996
Patterns of Ordering Diagnostic Tests for Patients with Acute Low Back Pain
Ann Int Med 125:807-814, Carey,T.S.,et al, 1996
Epilepsy and Sudden Death
Lancet 348:1324-1325, Nashef,L.&Brown,S., 1996
Variability in Brain Death Determination Practices in Children
JAMA 274:550-553, Mejia,R.E.&Pollack,M.M., 1995
Low Back Pain
BMJ 310:929-932, Jenner,J.R.&Barry,M., 1995
Acute Bacterial meningitis
Lancet 346:1675-1680, Tunkel,A.R.&Scheld,W.M., 1995